On this page

Vimal endorsers respond to Maharashtra FDA notices over alleged surrogate advertising

Our read

Audit Maharashtra-facing brand-extension campaigns and celebrity endorsement controls for surrogate-advertising exposure, as Vimal’s case has progressed without a reported final FDA action.

The report,

Maharashtra FDA completed hearings for two endorsers on 28 September in the Vimal Elaichi advertising case. Shah Rukh Khan, Ajay Devgn and Tiger Shroff responded to notices over alleged surrogate advertising for Vimal pan masala, banned in Maharashtra. Further action is pending.

  • Banaraswala: 3 → 50 outlets by March 2027
  • Nestle India: Sales +20.5% · Profit +36.3%

Reported figures

From the report. Source details below

  • 2006

Why it matters for the brand

For deals involving pan-masala-linked FMCG brands, scrutinize advertising compliance and endorsement contracts, distinguishing unresolved allegations from confirmed regulatory liabilities.

What to track next

Likely next moves

Our read of what comes next — analysis, not reported by the source.

  • Vimal and its agencies are likely to review campaign creatives and evidence supporting the advertised product's identity and claims.

The source

Source Read the source at Business Today

Published

First seen

By

AI use Written by AI from the cited report; not reviewed by a person before publishing.

Note Information, not investment advice. RetailIntel is not registered with SEBI.